References
- Schoolcraft W, Sinton E, Schlenker T, et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991; 55: 563–6
- Silverberg S G, Haukkamaa M, Arko H, et al. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986; 5: 235–41
- Harada T, Yoshida S, Katagiri C, et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995; 10: 1060–4
- Mio Y, Sekijima A, Iwabe T, et al. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992; 58: 159–66
- Fleming R, Coutts JRT. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986; 45: 226–30
- Gonen Y, Dirnfield M, Goldman S, et al. Preovulatory progesterone growth rate in patients treated with gonadotrophin-releasing hormone agonist and outcome of in vitro fertilization. Hum Reprod 1993; 8: 1376–9
- Bourgain C, Smitz J, Camus M, et al. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. Hum Reprod 1994; 9: 32–40
- Dirnfeld M, Goldman S, Gonen Y, et al. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization–embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993; 10: 126–9
- Fanchin R, de Ziegler D, Taieb J, et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993; 59: 1090–4
- Sims J A, Seltman H J, Muasher S J. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in vitro fertilization. Hum Reprod 1994; 9: 235–40
- Judd S, Terry A, Petrucco M, et al. The source of pulsatile secretion of progesterone during the human follicular phase. J Clin Endocrinol Metabol 1992; 74: 299–305
- New M I. Clinical and endocrinological aspects of 21-hydroxylase deficiency. Ann NY Acad Sci 1985; 458: 1–27
- Saketos M, Sharma LOL, Santoro N F. Suppression of the hypothalamic–pituitary–ovarian axis in normal women by glucocorticoids. Biol Reprod 1993; 49: 1270–6
- Kim-Bjorklund T, Landgren B M, Johannisson E. Morphometric studies of the endometrium, the fallopian tube and the corpus luteum during contraception with the 300 g norethisterone (NET) minipill. Contraception 1991; 43: 459–74
- Silverberg K M, Burns W N, Olive D L, et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropin. J Clin Endocrinol Metabol 1991; 73: 797–803
- Song J Y, Markham R, Russell P, et al. The effect of high-dose medium- and long-term progestogen exposure on endometrial vessels. Hum Reprod 1995; 10: 797–800
- Hourihan H M, Sheppard B L, Bonnar J. A morphometric study of the effect of oral nore-thisterone or levonorgestrel on endometrial blood vessels. Contraception 1986; 34: 603–12
- Hourihan H M, Sheppard B L, Belsey E M, et al. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 1991; 43: 375–85